Enhancer and metabolic rewiring by KMT2C–COMPASS or KMT2D–COMPASS family loss in cancer creates druggable vulnerabilities

Nature reviews. Cancer 2026

View at publisher

Authors: Zibo Zhao, Ali Shilatifard

DOI: 10.1038/s41568-026-00919-x

Cited by: 3

References: 116

Fields of Study & Subjects

Epigenetics and DNA Methylation Genomics and Rare Diseases Acute Myeloid Leukemia Research

References 116